drugset / Trial / NCT07835295
REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential Monitoring
RandomizedParallel-groupTriple-blindOther
Summary
The purpose of this research is to compare four commonly used anesthesia medication strategies for placing a breathing tube in patients undergoing spine surgery that requires motor evoked potential (MEP) monitoring.
Timeline
- Start
- 2026-09
- Primary completion
- 2028-09
- Completion
- 2029-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remifentanil | Small molecule | 2 mg/kg | Intravenous |
| Subject | Remifentanil | Small molecule | 4 mg/kg | Intravenous |
| Comparator | Rocuronium | Other / unclassified | 0.6 mg/kg | Intravenous |
| Comparator | Sugammadex | Other / unclassified | — | — |
| Comparator | Suxamethonium | Other / unclassified | 1 mg/kg | Intravenous |
Indications
No indication recorded.